[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.90.95. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Poster Presentations: American Head and Neck Society
August 2006

P182 Clinical Application of Epigenetic Biomarkers in Head and Neck Cancer

Arch Otolaryngol Head Neck Surg. 2006;132(8):900-901. doi:10.1001/archotol.132.8.900-c

University of Liverpool, Liverpool, England;

University Hospital Aintree, Liverpool

Objectives: While the crucial role of epigenetics in cancer is now being realized, this field has not yet been exploited for clinical benefit in head and neck squamous cell carcinoma (HNSCC). Our objective was to evaluate the biomarker possibilities of DNA promoter methylation.

Patients: Seventy-nine patients with HNSCC undergoing surgical resection.

First Page Preview View Large
First page PDF preview
First page PDF preview
×